Van Soolingen D. Molecular epidemiology of tuberculosis and other mycobacterial infections: main methodologies and achievements. J Int Med. 2001;249(1):1–26.

Article  Google Scholar 

Lee SH. Tuberculosis infection and latent tuberculosis. Tuberc Respir Dis. 2016;79(4):201–6.

Article  Google Scholar 

Thorson A, Diwan VK. Gender inequalities in tuberculosis: aspects of infection, notification rates, and compliance. Curr Opin Pulm Med. 2001;7(3):165–9.

Article  CAS  PubMed  Google Scholar 

National Department of Health. National Tuberculosis Management Guidelines 2014. TB DOTS Strategy Coordination, National Department of Health. Department of Health, Republic of South Africa 2014. https://knowledgehub.health.gov.za/elibrary/nationaltuberculosis-management-guidelines. Accessed May 2023.

Centers of Disease control and prevention (CDC). Basic TB facts. March 20, 2016. http://medbox.iiab.me/modules/encdc/www.cdc.gov/tb/topic/basics/default.htm. Accessed May 2023.

World Health Organization. Global tuberculosis report 2021. Geneva: World Health Organization; 2021. https://iris.who.int/bitstream/handle/10665/346387/9789240037021-eng.pdf?sequence=.

Abate, D., Taye, B., Abseno, M. et al. Epidemiology of anti-tuberculosis drug resistance patterns and trends in tuberculosis referral hospital in Addis Ababa, Ethiopia. BMC Res Notes. 5;462:2012. https://doi.org/10.1186/1756-0500-5-462.

Elorza E, Guillen S. Multidrug Resistant Tb and Extensively Drug Resistant TB. Rev Esp sanid Penit. 2010;12:91-8.

World Health Organization. Global tuberculosis report 2017. Geneva, Switzerland:

Tola A, Minshore KM, Ayele Y, Mekuria AN. Tuberculosis Treatment Outcomes and Associated Factors among TB Patients AttendingPublic Hospitals in Harar Town, Eastern Ethiopia: A Five-Year Retrospective Study. Tuberc Res Treat. 2019;2019:1503219. https://doi.org/10.1155/2019/1503219.

Negash H, Legese H, Adhanom G, Mardu F, Tesfay K, GebreslasieGebremeskel S, Berhe B, Six year’s trend analysis of tuberculosis in Northwestern Tigrai, Ethiopia,. A retrospective study. Infect Drug Resist. 2019;2020:643–9.

Google Scholar 

Mohammed H, Oljira L, Roba KT, Ngadaya E, Ajeme T, Haile T, Kidane A, Manyazewal T, Fekadu A, Yimer G. Burden of tuberculosisand challenges related to screening and diagnosis in Ethiopia. J Clin Tuberc Other Mycobact Dis. 2020;19:100158. https://doi.org/10.1016/j.jctube.2020.100158.

Dabaro D. Factors affecting tuberculosis case detection in Kersa district, south west Ethiopia. J Clin Tuberc Other Mycobact Dis. 2017;9:1–4.

Article  PubMed  PubMed Central  Google Scholar 

World Health Organization. Anti-Tuberculosis Drug Resistance in the World: Fourth Global Report. The World Health Organization/International Union Against Tuberculosis and Lung Disease (WHO/UNION) Global Project on Anti-Tuberculosis DrugResistance Surveillance 2002–2007. Geneva: World Health Organization 2008. WHO/HTM/TB/2008.394.

Wasihun AG, Hailu GG, Dejene TA. Prevalence of Mycobacterium tuberculosis (Rifampicin-Resistant MTB) and associated risk actors among pulmonary presumptive TB patients in Eastern Amhara, Ethiopia: 2015–2019. Infectious Diseases and Therapy. 2021;10(3):1299–308.

Article  PubMed  PubMed Central  Google Scholar 

Abebe G, Abdissa K, Abdissa A, Apers L, Agonafir M, de-Jong BC, Colebunders R. Relatively low primary drug resistant tuberculosis in southwestern Ethiopia. BMC Res Notes. 2012;5(1):1–6.

Article  Google Scholar 

Tiberi S, Utjesanovic N, Galvin J, Centis R, D’Ambrosio L, van den Boom M, Zumla A, Migliori GB. Drug resistant TB–latest developments in epidemiology, diagnostics and management. Int J Infect Dis. 2022;124:S20–5.

Article  CAS  PubMed  Google Scholar 

World Health Organization. Global tuberculosis report 2020. Geneva: World Health Organization; 2020.https://reliefweb.int/report/world/global-tuberculosis-report-2020?.

Xi Y, Zhang W, Qiao RJ, Tang J. Risk factors for multidrug-resistant tuberculosis: A worldwide systematic review and meta-analysis. PloS one. 2022;16(6):e0270003.

Article  Google Scholar 

Mehari K, Asmelash T, Hailekiros H, Wubayehu T, Godefay H, Araya T, Saravanan M. Prevalence and Factors Associated with Multidrug-Resistant Tuberculosis (MDR-TB) among Presumptive MDR-TB Patients in Tigray Region, Northern Ethiopia. Can J Infect Dis Med Microbiol. 2019;2019:2923549. https://doi.org/10.1155/2019/2923549.

Abay GK, Abraha BH. Trends of Mycobacterium tuberculosis and rifampicin resistance in Adigrat General Hospital, eastern zone of Tigrai, North Ethiopia. Trop Dis Travel Med Vaccines. 2020;6:1–9.

Article  Google Scholar 

Ethiopia Statistic service (ESS) 2022. https://www.statsethiopia.gov.et/population-projection. Accessed 10 June 2023.

Gebregziabher M, Amdeselassie F, Esayas R, Abebe Z, Silvia H, Teklehaimanot AA, Korte JE, Pearce JL, Cochran JJ. Geographical distribution of the health crisis of war in the Tigray region of Ethiopia. BMJ Global Health. 2022;7(4):e008475.

Article  PubMed  PubMed Central  Google Scholar 

https://www.facebook.com/495533130603049/posts/back-ground-of-akuchs-referral-hospital-akuchs-rhthe-city-of-aksum-emerged-sever/508109039345458/ accessed on June 15,2023

Selfegna S, Alelign A. Detection of Mycobacterium tuberculosis and Rifampicin Resistance Using GeneXpert MTB/RIF Assay at Enat Hospital, Central Ethiopia. Tuberc Res Treat. 2022;2022:1250404. https://doi.org/10.1155/2022/1250404.

Araya S, Negesso AE, Tamir Z. Rifampicin-Resistant Mycobacterium tuberculosis Among Patients with Presumptive Tuberculosis in Addis Ababa, Ethiopia. Infect Drug Resist. 2020;13:3451-3459. https://doi.org/10.2147/IDR.S263023.

Abayneh M, Teressa M. Detection of Mycobacterium tuberculosis using Gene Xpert-MTB/RIF assay among tuberculosis suspected patients at Mizan-Tepi university teaching hospital, southwest Ethiopia: An institution based cross-sectional study. Plosone. 2022;17(11): e0277536.

Article  CAS  Google Scholar 

Asfaw T, Terefe A, Nigus M. Patterns and trends of rifampicin-resistance Mycobacterium tuberculosis and associated factors among presumptive tuberculosis patients at DebreBerhan Referral Hospital. J Bioprocess Biotech. 2018;8:339.

Google Scholar 

Derbie A, Worku S, Mekonnen D, Mezgebu Y, Teshager A, Birhan A, Zenebe Y, Bereded F, Adem Y, Yizengaw E, Tulu B. Xpert MTB/RIF assay for the diagnosis of Mycobacterium tuberculosis and its Rifampicin resistance at Felege Hiwot and Debre Tabor Hospitals, Northwest Ethiopia: A preliminary implementation research. Ethiop J Health Dev. 2016;30(2):60–6.

Google Scholar 

GebremeskelMirutse Tuberculosis treatment outcome. The case of women in Ethiopia and China. Ten Years Retrospective Cohort study. 2019. https://doi.org/10.1101/676924.

Article  Google Scholar 

Haile A, Haile K, Shemsu S. Trend and Associated Factors of Mycobacterium Tuberculosis and Rifampicin Resistance in Southwest Ethiopia: Institutional Based Retrospective Study. Health Sci J. 2021;15(9):1–6.

Google Scholar 

Alemu T, Gutema H. Trend in magnitude of tuberculosis in Awi Zone, Northwest Ethiopia: a five-year tuberculosis surveillance data analysis. BMC Res Notes. 2019;12:1–5.

Article  Google Scholar 

Mengesha D, Manyazewal T, Woldeamanuel Y. Five-year trend analysis of tuberculosis in Bahir Dar, Northwest Ethiopia, 2015–2019. Int J Mycobacteriology. 2021;10(4):437.

Article  Google Scholar 

Jaleta KN, Gizachew M, Gelaw B, Tesfa H, Getaneh A, Biadgo B. Rifampicin-resistant Mycobacterium tuberculosis among tuberculosispresumptivecases at University of Gondar Hospital, northwest Ethiopia. Infect Drug Resist. 2017;10:185-192. https://doi.org/10.2147/IDR.S135935.

Hasen Badeso M, Sani Kalil F, Mohammed Ahmed Y, Abdulkadir Godie S, Habtamu Regesu A. Trends of Tuberculosis Disease from 2013-2018 in Bale Zone, Oromia Region, Ethiopia. Retrospective Review. Infect Drug Resist. 2022;15:6723-30. https://doi.org/10.2147/IDR.S384402.

Zewudie S, Sirna A, Terefe A, Asres A. Trends and outcomes of tuberculosis among cases on directly observed short course treatment(DOTS) at Tepi public health center Southwest Ethiopia. J Clin Tuberc Other Mycobact Dis. 2021;25:100264. https://doi.org/10.1016/j.jctube.2021.100264.

WondemagegnMulu BayehAbera. MulatYimer, TadesseHailu, HaimanotAyele and Dereje Abate Rifampicin-resistance pattern of Mycobacterium tuberculosis and associated factors among presumptive tuberculosis patients referred to DebreMarkos Referral Hospital, Ethiopia: a cross-sectional study. BMC Res Notes. 2017;10:8. https://doi.org/10.1186/s13104-016-2328-4.

Article  Google Scholar 

Ikuabe PO, Ebuenyi ID. Prevalence of rifampicin resistance by automated Genexpert rifampicin assay in patients with pulmonary tuberculosis in Yenagoa, Nigeria. Pan Afr Med J. 2018;29:204. https://doi.org/10.11604/pamj.2018.29.204.14579.

Oyedeji GJ, Adeyemo C, Dissou A, Abiodun T, Alli OA, Onaolapo OJ, Onaolapo AY, Adesiji Y, Olowe OA. Prevalence of multi-drug resistant tuberculosis among tuberculosis patients attending chest clinics in Osun-State. Nigeria Curr Pharm Biotechnol. 2020;21(10):939–47.

Article  CAS  PubMed  Google Scholar 

Semunigus T, Tessema B, Eshetie S, Moges F. Smear positive pulmonary tuberculosis and associated factors among homeless individuals in Dessie and DebreBirhan towns. Northeast Ethiopia Ann Clin Microbiol Antimicrob. 2016;15:1–8.

Google Scholar 

Wasihun AG, Dejene TA, Hailu GG. Frequency of MTB and rifampicin resistance MTB using Xpert-MTB/RIF assay among adult presumptive tuberculosis patients in Tigray, Northern Ethiopia: A cross sectional study. PLoS ONE. 2020;15(11): e0240361. https://doi.org/10.1371/journal.pone.0240361.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Alelign A, Petros B, Ameni G. Smear positive tuberculosis and genetic diversity of M. tuberculosis isolates in individuals visiting health facilities in South Gondar Zone, northwest Ethiopia. Plos one. 2019;14(8):e0216437.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kalonji GM, De Connick G, OkengeNgongo L, KazumbaNsaka D, Kabengele T, TshimunguKandolo F, Ilunga-Ilunga F, Adelin A, Giet D. Prevalence of tuberculosis and associated risk factors in the Central Prison of Mbuji-Mayi, Democratic Republic of Congo. Trop Med Health. 2016;44:1–6.

Article  Google Scholar 

Yang Y, Zhou C, Shi L, Meng H, Yan H. Prevalence and characterization of drug-resistant tuberculosis in a local hospital of Northeast China. Int J Infect Dis. 2014;22:83–6.

Article  PubMed  Google Scholar 

Masenga SK, Mubila H, Hamooya BM. Rifampicin resistance in mycobacterium tuberculosis patients using GeneXpert at Livingstone Central Hospital for the year 2015: a cross sectional explorative study. BMC Infect Dis. 2017;17(1):1–4.

Article  Google Scholar 

Shiluli C, Ouma C, Vulule J, Khayumbi J, Murithi W, Musau S, Okumu A. Mycobacterium tuberculosis resistance to isoniazid and rifampicin in a HIV-1 endemic population in western Kenya in 2012–2014. JMSCR. 2016;4(12):14605–12.

Article  Google Scholar 

Legesse T, Admenur G, Gebregzabher S, Woldegebriel E, Fantahun B, Tsegay Y, Bayssa A, Darge B, Denbu Y, Michalel H, Abera K. Tuberculosis (TB) in the refugee camps in Ethiopia: trends of case notification, profile, and treatment outcomes, 2014 to 2017. BMC Infect Dis. 2021;21(1):1–2.

Article  Google Scholar